HRTS ETF
Tema Heart & Health ETF
HRTS ETF Overview
HRTS ETF (Tema Heart & Health ETF) is managed by Tema Global Limited with $55.8M in net assets. HRTS expense ratio is 0.75%, holding 45 positions across sectors including Health Care, Financials. Inception date: 2023-11-20.
HRTS performance shows a YTD return of 2.89%. The 1-year return is 31.94%. HRTS dividend yield stands at 1.27%, paid annually.
HRTS top holdings include Eli Lilly & Co. (10.9%), Unitedhealth Group Incorporated (5.1%), Thermo Fisherscientific Inc. (5.0%), Novo Nordisk As (4.8%), Merck & Company Inc (4.3%). Go to all HRTS holdings, HRTS sectors, or HRTS dividends.
HRTS can be compared against other funds. Use HRTS overlap to find shared positions, or HRTS vs another fund for a side-by-side view. HRTS alternatives are available via the screener, along with tax-loss harvesting opportunities.